Gainers

Ardelyx Inc (NASDAQ:ARDX) shares rose 81.2% to $2.21 in pre-market trading as the company said the FDA Advisory Committee voted 9-To-4 that the benefits of XPHOZAH outweigh its risks for the control of serum phosphorus in adult patients with chronic kidney disease on dialysis. Elevate Credit, Inc. (NYSE:ELVT) shares rose 65.1% to $1.75 in pre-market trading after the company agreed to be acquired by Park Cities Asset Management in an all-cash transaction at an implied value of $67 million. Cuentas Inc. (NASDAQ:CUEN) rose 29.6% to $0.3239 in pre-market trading after dropping 28% on Wednesday. Cuentas authorized a share repurchase program...